» Articles » PMID: 20007911

Prostaglandin I2 Promotes Recruitment of Endothelial Progenitor Cells and Limits Vascular Remodeling

Abstract

Objective: Endothelial progenitor cells (EPCs) play an important role in the self-healing of a vascular injury by participating in the reendothelialization that limits vascular remodeling. We evaluated whether prostaglandin I(2) plays a role in the regulation of the function of EPCs to limit vascular remodeling.

Methods And Results: EPCs (Lin(-)cKit(+)Flk-1(+) cells) were isolated from the bone marrow (BM) of wild-type (WT) mice or mice lacking the prostaglandin I(2) receptor IP (IP(-/-) mice). Reverse transcription-polymerase chain reaction analysis showed that EPCs among BM cells specifically express IP. The cellular properties of EPCs, adhesion, migration, and proliferation on fibronectin were significantly attenuated in IP-deficient EPCs compared with WT EPCs. In contrast, IP agonists facilitated these functions in WT EPCs, but not in IP-deficient EPCs. The specific deletion of IP in BM cells, which was performed by transplanting BM cells of IP(-/-) mice to WT mice, accelerated wire injury-mediated neointimal hyperplasia in the femoral artery. Notably, transfused WT EPCs, but not IP-deficient EPCs, were recruited to the injured vessels, participated in reendothelialization, and efficiently rescued the accelerated vascular remodeling.

Conclusions: These findings clearly indicate that the prostaglandin I(2)-IP system is essential for EPCs to accomplish their function and plays a critical role in the regulation of vascular remodeling.

Citing Articles

Efficacy and safety of a 72-h infusion of prostacyclin (1 ng/kg/min) in mechanically ventilated patients with pulmonary infection and endotheliopathy-protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated....

Soe-Jensen P, Clausen N, Bestle M, Andersen L, Lange T, Johansson P Acta Anaesthesiol Scand. 2024; 69(1):e14565.

PMID: 39704260 PMC: 11660193. DOI: 10.1111/aas.14565.


Small molecules in the treatment of COVID-19.

Lei S, Chen X, Wu J, Duan X, Men K Signal Transduct Target Ther. 2022; 7(1):387.

PMID: 36464706 PMC: 9719906. DOI: 10.1038/s41392-022-01249-8.


The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.

Six I, Guillaume N, Jacob V, Mentaverri R, Kamel S, Boullier A Int J Mol Sci. 2022; 23(11).

PMID: 35682871 PMC: 9181280. DOI: 10.3390/ijms23116196.


The effect of prostacyclin infusion on markers of endothelial activation and damage in mechanically ventilated patients with SARS-CoV-2 infection.

Vigstedt M, Soe-Jensen P, Bestle M, Clausen N, Kristiansen K, Lange T J Crit Care. 2022; 69:154010.

PMID: 35183892 PMC: 8851884. DOI: 10.1016/j.jcrc.2022.154010.


Prostacyclin in Intubated Patients with COVID-19 and Severe Endotheliopathy: A Multicenter, Randomized Clinical Trial.

Johansson P, Soe-Jensen P, Bestle M, Clausen N, Kristiansen K, Lange T Am J Respir Crit Care Med. 2021; 205(3):324-329.

PMID: 34813414 PMC: 8886993. DOI: 10.1164/rccm.202108-1855OC.